drugset / Trial / NCT00535522
A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and pharmacokinetics of TAK-285 in patients with advanced cancer.
Timeline
- Start
- 2007-08
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-285 | Small molecule | 50 mg | Oral |
| Subject | TAK-285 | Small molecule | 400 mg | Oral |
| Subject | TAK-285 | Small molecule | 500 mg | Oral |